Quest Diagnostics

Working With the CDC and Others To Advance Understanding of SARS-CoV-2

Blog

“Public and private collaboration is essential to mobilizing an effective response to COVID-19.”
Jay G. Wohlgemuth, MD Chief Medical Officer, Senior Vice President, Research & Development

Hispanic Scholars Receive Financial Support for STEM Studies and Research

The American Heart Association Hispanic Serving Institutions Scholars program supports priority diversification in the pipeline of healthcare professionals with the support of the Quest Diagnostics
Press Release

DALLAS, August 5, 2022 /3BL Media/ - The American Heart Association, the world’s leading nonprofit organization focused on longer, healthier lives for all, is committed to addressing the lack of diversity and Hispanic inclusion in healthcare careers. As such, the AHA has announced that 30 students from across the United States and Puerto Rico have been selected to participate in the 2022-2023 Hispanic Serving Institution Scholars Program that begins in September.

COVID-19: Challenges, Accomplishments, and Opportunities

Article

As the world’s leading provider of diagnostic information services, Quest stepped up and answered the call to play a central role in the national response to COVID-19.

Quest for Health Equity Supports Kansas City Charity Working to Support Homeless Youth

Blog

Serve the World Charities, Inc. (STW), which recently received a grant from Quest Diagnostics Incorporated, hosted its first annual “Friendraiser” event. STW held the event to raise awareness and funding to support their mission to empower families in South Kansas City to find affordable, dignified, and permanent housing, while helping to distribute food and providing safe and fun community events for all.

Board of Directors Oversight on Corporate Responsibility and ESG

Article

The Board of Directors has aligned its activities to oversee the organization from an ESG perspective. Different committees of the Board and, in some cases the full Board itself, oversee various areas. Each committee’s responsibilities are included in its charter, and the full Board’s ESG responsibilities are set forth in the company’s Corporate Governance Guidelines. For example, the Governance Committee oversees the organization’s overall ESG priorities, goals, and strategies and also reviews policies, programs, and reports pertaining to environmental sustainability matters.

A Conversation With Quest Diagnostics' CEO-Elect Jim Davis

Article

James E. Davis is the Chief Executive Officer (CEO)-elect and Executive Vice President, General Diagnostics, for Quest Diagnostics. As Executive Vice President, General Diagnostics, Jim managed all diagnostic testing services and the company’s operations, including sales and marketing, patient and customer services, laboratories, logistics, and billing. He has also provided enterprise oversight for Quest’s COVID-19 response, including rapid expansion of testing capacity and testing innovation.

Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Fifth Consecutive Year

Press Release

SECAUCUS, N.J., August 8, 2022 /3BL Media/ - Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2022 Disability Equality Index® (DEI) Best Places to Work for Disability Inclusion by Disability: IN and the American Association of People with Disabilities (AAPD).

Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide

Testing available at no out-of-pocket cost for qualified insured individuals at Rite Aid drive-thru locations with appointment; at all other Rite Aid locations customers can schedule to pick up at-home specimen collection kits for PCR testing
Press Release

PHILADELPHIA & SECAUCUS, N.J., August 16, 2022 /3BL Media/ - Rite Aid (NYSE: RAD) announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing (polymerase chain reaction or similar nucleic acid amplification test) to help Rite Aid customers detect and prevent the spread of COVID-19.

“PCR and other molecular diagnostic tests are the gold-standard for reliable COVID-19 testing. Our relationship with Rite Aid will extend our delivery of COVID-19 testing to more communities in the United States.”

A Letter From Quest Diagnostics' Chairman, CEO, and President

Blog

I am pleased to share our 2021 Corporate Responsibility report.

In 2021, we introduced new diagnostic initiatives, innovative partnerships, and research efforts, remaining passionately committed to our company’s vision of “Empowering better health with diagnostic insights.” Our dedicated team members were able to do this despite working around the clock for a second year to meet demand for COVID-19 testing, bringing the total to 63 million tests.

High Rates of Chronic Hepatitis B and Tuberculosis Co-Infection Observed in Nationally Representative Quest Diagnostics Study

Summary: 

Analysis of nearly 23 million lab tests finds only 1 in 3 patients with latent tuberculosis were also tested for chronic hepatitis B, despite similar risk factors in patients

Findings heighten caution about use of tuberculosis therapies, which raise risk of liver injury in patients co-infected with chronic hepatitis B virus

Press Release

Analysis of nearly 23 million lab tests finds only 1 in 3 patients with latent tuberculosis were also tested for chronic hepatitis B, despite similar risk factors in patients

Findings heighten caution about use of tuberculosis therapies, which raise risk of liver injury in patients co-infected with chronic hepatitis B virus

Pages

Subscribe to Quest Diagnostics